$OSCR

Oscar Health Reports Another Big Profit As Obamacare Member Costs Ease

Oscar Health reported a $361.8 million Q2 profit and $1.04 billion net income for the first six months of 2026, with revenue up 70% year over year to $4.9 billion. Membership rose to 2.9 million. Oscar said its medical loss ratio fell to 79.2% from 91.1% and raised its 2026 outlook, citing cost control and prior-period reserve development.

Original reporting
Published Aug 6, 2026, 10:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 10:39 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Oscar Health Reports Another Big Profit As Obamacare Member Costs Ease — source image
Decision brief

The 30-second read

$OSCRBullishMed
01

Why it matters

The key tradable update is the combination of a large Q2 profit, a major year-over-year net income swing, a quantified MLR drop, and an outlook raise for the rest of 2026.

02

Market read

Earnings and guidance details suggest improving profitability and lower medical-cost risk in the ACA individual market, which can drive re-rating versus peers.

03

What to watch

Risk adjustment true-up dynamics and member mix changes can swing medical cost trends; the article does not quantify how much of the outlook raise depends on one-time reserve effects.

Relevance 8/10Novelty 7/10Timing: reported Q2 results and raised 2026 outlook on Aug 6, 2026

Background

Oscar is a major ACA individual-market insurer; it has been working to deliver consistent quarterly profits after earlier struggles.

Company-level read

Ticker impact

$OSCRBullishMedium confidence
Context

Oscar reported Q2 net income of $361.8M and raised its 2026 outlook, citing a lower medical loss ratio to 79.2%.

Expected impact

Likely positive near-term bias as traders price sustained individual-market profitability and lower medical-cost risk.

Evidence & confidence

The article discloses specific earnings results, a quantified MLR improvement, and an outlook increase, all of which directly affect OSCR’s forward earnings expectations.

Market effects

Supports the narrative that individual ACA insurers can regain profitability via disciplined pricing and reserve development, pressuring weaker competitors’ exit/strategy assumptions.

Limited, primarily US health insurance equities and managed-care sentiment.

Low, largely domestic reimbursement and risk-adjustment dynamics.

Counterpoint

MLR improvement may be partly driven by favorable prior-period reserve development, which can reverse and reduce durability of the margin trend.

Key entities

  • Oscar Health

    Reported Q2 profit, improved medical loss ratio, and raised 2026 outlook.

  • Mark Bertolini

    Oscar’s top executive, cited in the earnings statement supporting the outlook.

Related articles

$OSCRMedAI 8/10

Oscar Health (OSCR) Q2 2026 Earnings Call Transcript

Oscar Health (OSCR) reported Q2 2026 revenue of $4.9B, up 70% year over year, and net income of $362M. Effectuated membership rose to 2.96M, and medical loss ratio improved to 79.2%. Management reiterated full-year revenue guidance of $18.7B to $19.0B and raised earnings from operations guidance to $500M to $700M, citing disciplined pricing and favorable prior-period reserves, while noting potential higher churn from CMS eligibility verification.

$OSCRMed

GoodRx and Oscar Health Tout Tech as Consumer Needs Change

GoodRx reported Q2 revenue of $200.4M, down 1%, and raised its full-year outlook, citing a projected 70% revenue increase from Pharma Direct. Oscar Health reported first-half 2026 results with revenue up 70% to $4.9B and record profitability, attributing gains to its AI platform and “Oswal” tools. Both cited shifting consumer insurance needs.

$OSCRMed

Oscar Health, Inc. Q2 2026 Earnings Call Summary

Oscar Health, Inc. reported record first-half profitability with $1 billion net income and improved medical loss ratio, citing disciplined pricing and favorable utilization. The company raised 2026 earnings from operations guidance to $500 million to $700 million, with full-year MLR expected at 81.5% to 82.5% and SG&A ratio 15.6% to 16.1%. It highlighted AI tools and CMS program integrity reviews.

$OSCRHigh

Oscar Health, Inc. (OSCR): Results of Operations and Financial Condition

Oscar Health, Inc. (OSCR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 oscarhealthsecondquarter20.htm EX-99.1 Document Oscar Health, Inc. ir.hioscar.com News Release Oscar Health Announces Record Financial Results for First Half 2026 and Raises Full Year 2026 Outlook New York, NY, August 6, 2026 – Oscar Health, Inc. (“Oscar” or the “Compan

$OSCRMedAI 8/10

Oscar Health Stock Is Trending After Jumping 12% On Monday: What's Going On? - Oscar Health (NYSE:OSCR)

Oscar Health (NYSE:OSCR) shares rose 11.75% to $27.39 on Monday and added 0.77% to $27.60 after hours, after management cited favorable operating trends at the Goldman Sachs 47th Annual Global Healthcare Conference. CFO Scott Blackley said 2026 is off to a “very strong start,” with utilization modestly favorable through May and a final 2025 Wakely report $130 million better than first-quarter assumptions. Oscar reiterated 2026 guidance: revenue $18.7B–$19B and operating earnings $250M–$450M.